Home Tools
Log in
Cart

Search Result

Search Results for " slamf5 "
All TargetMol products are for research or drug registration purposes only and cannot be used for human consumption.
We do not provide products or services to individuals.
Please comply with the intended use and do not use TargetMol products for any other purpose in violation of laws and regulations.

6

Recombinant Proteins

Recombinant Proteins

Cat No. Product Name Species Expression System
TMPJ-00229 SLAMF5 Protein, Human, Recombinant (His) Human HEK293 Cells
SLAMF5 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-6xHis tag. The predicted molecular weight is 35-43 KDa and the accession number is Q9UIB8.
TMPJ-00455 SLAMF5 Protein, Mouse, Recombinant (His) Mouse HEK293 Cells
CD84, also called SLAMF5, is a member of the CD2 subgroup of the immunoglobulin receptor superfamily. Members of this CD2 subgroup mediate signal transduction through the interaction of its immunoreceptor tyrosine-based ...
TMPJ-00228 SLAMF5 Protein, Human, Recombinant (His & Avi), Biotinylated Human HEK293 Cells
SLAMF5 Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-6xHis-Avi tag. The predicted molecular weight is 40-50 KDa and the accession number is Q9UIB8.
TMPY-02454 CD84 Protein, Mouse, Recombinant (His) Mouse HEK293 Cells
CD84 Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is Q18PI6-1.
TMPY-00715 CD84 Protein, Human, Recombinant (His) Human HEK293 Cells
CD84 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 24 kDa and the accession number is Q9UIB8-3.
TMPK-00234 CD84 Protein, Human, Recombinant (His & Avi) Human HEK293 Cells
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of CD5 B lymphocytes in peripheral blood, lymphoid organs and bone marrow. The main feature of the disease is accumulation of the malignant cells du...
TargetMol